MS-Omics
MS-Omics is a Denmark-based metabolomics and data analysis service provider, now operating as part of Cmbio, delivering end-to-end multi-omics microbiome research services to academic institutions, hospitals, and life sciences companies across the US, EU, and APAC.
- Company typePrivate
- Founded2014
- HeadquartersVedbæk, Denmark
- Headcount1–10
- GTM typeB2B
- OfferingServices
What MS-Omics does
MS-Omics is a Denmark-based metabolomics and data analysis service provider founded in 2014 and headquartered in Vedbæk. It is one of four founding entities — alongside Clinical Microbiomics, CosmosID, and DNASense — that merged to form Cmbio, a multi-omics research partner operating EU labs in Copenhagen and US labs in Germantown, Maryland with claimed reach into APAC. The combined organization provides end-to-end microbiome research services spanning shotgun and long-read metagenomics, marker gene analysis, metabolomics (untargeted and targeted), metatranscriptomics, metaproteomics, microbial strain characterization, and biostatistics, unified by the Cosmos-Hub cloud bioinformatics platform and an integrated systems biology layer.
The core technology stack combines wet-lab sequencing (including long-read platforms), mass-spectrometry-based metabolomics, and downstream bioinformatics with applied machine learning for pattern recognition and predictive modeling. Service delivery is consultative and project-based, with quote-based pricing and multi-year contracts; the company does not publish list pricing. Customer segments span academic medical centers, hospitals, biotech and nutritional-supplement companies, agricultural/aquaculture operators, environmental monitoring clients, and a newly added direct-to-consumer testing channel — supported by a content-led go-to-market that emphasizes peer-reviewed publications, case studies, webinars, and customer testimonials rather than paid acquisition.
The business model is professional services revenue from custom research engagements, supplemented by software usage of Cosmos-Hub and (potentially) future DTC monetization. The MS-Omics standalone legal entity (MS-Omics ApS) remains part of the Cmbio group; no funding rounds, patents, awards, or revenue figures are disclosed, and ownership is private. The most strategically significant move to date is the four-way merger that consolidated wet-lab metabolomics, metagenomics, transcriptomics, and bioinformatics under a single brand.
MS-Omics firmographics
Firmographics- Name
- MS-Omics
- Legal name
- MS-Omics ApS
- Website
- https://msomics.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MS-Omics is a Denmark-based metabolomics and data analysis service provider, now operating as part of Cmbio, delivering end-to-end multi-omics microbiome research services to academic institutions, hospitals, and life sciences companies across the US, EU, and APAC.
- Ownership category
- akta.pro rank
MS-Omics industry classification
Industry- Product category
- Multi-omics Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (541690), Computer Systems Design and Related Services (54151)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)
- akta.pro secondary industries
- Microbiome & Metagenomics Services (HLAGANAH), Bioinformatics & Multi-omics Analysis Software (HLAGAJAD), Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Proteomics & Mass Spectrometry Services (HLAGANAB)
Keywords
Where MS-Omics is headquartered
LocationHeadquarters
- HQ city
- Vedbæk
- HQ country
- Denmark
- HQ region
- Europe
Offices2 records
Markets served
MS-Omics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Multi-omics Research Services: Comprehensive microbiome research services including sequencing (metagenomics, transcriptomics), metabolomics, proteomics, and bioinformatics analysis. Provided as end-to-end service engagements to research institutions and companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing for research services |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
MS-Omics product offering
Product offeringCore offering
MS-Omics is a contract research services provider delivering end-to-end multi-omics studies for microbiome scientists and science-driven companies. Its service portfolio covers shotgun and long-read metagenomics, marker gene analysis, microbiome profiling, absolute abundance, metabolomics (untargeted and targeted), metatranscriptomics/transcriptomics, proteomics, metaproteomics, 16S bacterial genome sequencing, and microbial strain characterization, supported by custom sampling kits and a cloud-based bioinformatics platform (Cosmos-Hub) for integrative multi-omics analysis, biostatistics, strain tracking, and machine learning/AI services.
Product overview
Cmbio (incorporating MS-Omics) offers a comprehensive multi-omics service portfolio organized across four main pillars: (1) Core Sequencing Services including Shotgun Metagenomics, Long-Read Metagenomics, Marker Gene Analysis, Microbiome Profiling, Absolute Abundance, and Direct-to-Consumer Testing; (2) Core Omics Services encompassing Metabolomics, Metatranscriptomics/Transcriptomics, Proteomics, and Metaproteomics; (3) Genomics Services for Microbial Strain Characterization and Bacterial Genome Sequencing; and (4) Bioinformatics Services including Biostatistics, Integrative Systems Biology/Multi-omics, Strain Tracking and Engraftment, and Machine Learning/AI Services. The portfolio is unified by the Cosmos-Hub cloud-based bioinformatics platform for data analysis. The company also provides Sampling Kits and Project Handling as support services. This end-to-end offering enables researchers to generate meaningful insights from complex microbiome data across human health, animal health, and environmental applications.
Differentiator
Problem solved
Functional benefit
Products and services
- Shotgun Metagenomics Comprehensive sequencing of all microbial DNA to analyze taxonomic composition and functional potential, enabling high-resolution microbiome analysis across multiple species in complex microbial communities with robust pipelines and quality controls that minimize false positives.
- Long-Read Metagenomics
- Marker Gene Analysis
- Microbiome Profiling
- Absolute Abundance
- Direct-to-Consumer Testing
- Metabolomics Services
- Metatranscriptomics and Transcriptomics Services
- Proteomics Services
- Metaproteomics
- Bacterial Genome Sequencing (16S rRNA)
- Microbial Strain Characterization
- Sampling Kits and Project Handling
- Biostatistics
- Integrative Systems Biology and Multi-omics Services
- Strain Tracking and Engraftment
- Machine Learning and AI Services
- Cosmos-Hub (Bioinformatics Platform)
Quantifiable outcome
- Minimized false positives through robust pipelines and quality controls
Companies that use MS-Omics
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
MS-Omics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature7 records
MS-Omics partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights6 records
MS-Omics competitors and assessment
Company assessmentEmerging players
- Velsera (formerly Seven Bridges): Velsera operates a cloud bioinformatics platform for genomics and multi-omics analysis, overlapping with Cmbio's Cosmos-HUB software and competing for enterprise customers that need scalable analysis infrastructure.
- DNAnexus: DNAnexus is a cloud-based bioinformatics platform supporting genomics and multi-omics pipelines; it competes with the Cosmos-HUB portion of MS-Omics/Cmbio for enterprise research informatics contracts.
Direct peers
- CD Genomics: CD Genomics is a multi-omics services CRO offering metagenomics, transcriptomics, epigenomics, and bioinformatics — overlapping heavily with Cmbio's omics service portfolio for global research customers.
- Diversigen: Diversigen (now part of OraSure Technologies) provides end-to-end microbiome sequencing and bioinformatics services, directly competing with MS-Omics/Cmbio on shotgun metagenomics, 16S, and multi-omics projects for academic and biopharma customers.
- Clinical Microbiomics: Clinical Microbiomics is a Danish microbiome services specialist that merged with MS-Omics, CosmosID, and DNASense to form Cmbio. It is the closest historical peer, with overlapping metagenomics and bioinformatics capabilities for clinical microbiome research.
- Novogene: Novogene is a global genomics services provider with strong metagenomics, microbiome, and bioinformatics offerings; competes with MS-Omics on price, scale, and turnaround time for sequencing-heavy projects.
- Zymo Research: Zymo Research offers microbiome collection devices, kits, and a microbiome research services arm that competes head-to-head with MS-Omics' shotgun metagenomics and marker gene services, often as a bundled product+service solution.
Broad incumbents
- Eurofins Genomics: Eurofins Genomics is a large incumbent sequencing and bioinformatics services provider with a broad portfolio (including microbiome and multi-omics) that competes with MS-Omics, especially for European customers and standardized service offerings.
- BGI Group: BGI is one of the largest global genomics and multi-omics service providers, offering metagenomics, metabolomics, and proteomics at scale. It is a broad incumbent whose services compete with Cmbio's portfolio, particularly on cost and throughput.
- QIAGEN Digital Insights: QIAGEN provides broad bioinformatics and omics interpretation tools and services, including microbiome analysis, and is a broad incumbent competing with both MS-Omics' services and software offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
MS-Omics social profiles
Digital presenceMS-Omics financial estimates
Financial estimateRevenue estimate
Valuation estimate
MS-Omics leadership team
Management profileNumber of profiles
MS-Omics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MS-Omics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MS-Omics
What does MS-Omics do?
MS-Omics is a contract research services provider delivering end-to-end multi-omics studies for microbiome scientists and science-driven companies. Its service portfolio covers shotgun and long-read metagenomics, marker gene analysis, microbiome profiling, absolute abundance, metabolomics (untargeted and targeted), metatranscriptomics/transcriptomics, proteomics, metaproteomics, 16S bacterial genome sequencing, and microbial strain characterization, supported by custom sampling kits and a cloud-based bioinformatics platform (Cosmos-Hub) for integrative multi-omics analysis, biostatistics, strain tracking, and machine learning/AI services.
Is MS-Omics a public or private company?
MS-Omics is a private company. It is classified as corporate owned and is currently operating.
When was MS-Omics founded?
MS-Omics was founded in 2014. It employs 1 to 10 people.
Where is MS-Omics based?
MS-Omics is headquartered in Vedbæk, Denmark, in the Europe region.
How does MS-Omics make money?
One revenue line is on record: multi-omics Research Services.
Who are MS-Omics's main competitors?
Emerging players on record are Velsera (formerly Seven Bridges) and DNAnexus. Direct peers are CD Genomics, Diversigen, Clinical Microbiomics, Novogene and Zymo Research. Broad incumbents are Eurofins Genomics, BGI Group and QIAGEN Digital Insights.
Does MS-Omics have an API?
No public API is recorded for MS-Omics.
What industry is MS-Omics in?
MS-Omics's product category is Multi-omics Research Services. Its primary akta.pro industry code is HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services, with a secondary code of HLAGANAH, Microbiome & Metagenomics Services. Its NAICS code is 541714 and its SIC code is 8731.